| Title |
Fluoroquinolones for treating tuberculosis (presumed drug‐sensitive)
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2013
|
| DOI | 10.1002/14651858.cd004795.pub4 |
| Pubmed ID | |
| Authors |
Lilia E Ziganshina, Albina F Titarenko, Geraint R Davies |
| Abstract |
Currently the World Health Organization only recommend fluoroquinolones for people with presumed drug-sensitive tuberculosis (TB) who cannot take standard first-line drugs. However, use of fluoroquinolones could shorten the length of treatment and improve other outcomes in these people. This review summarises the effects of fluoroquinolones in first-line regimens in people with presumed drug-sensitive TB. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 324 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Austria | 1 | <1% |
| Brazil | 1 | <1% |
| South Africa | 1 | <1% |
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 319 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 47 | 15% |
| Student > Ph. D. Student | 34 | 10% |
| Researcher | 32 | 10% |
| Student > Bachelor | 28 | 9% |
| Other | 22 | 7% |
| Other | 68 | 21% |
| Unknown | 93 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 106 | 33% |
| Nursing and Health Professions | 20 | 6% |
| Agricultural and Biological Sciences | 17 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 4% |
| Biochemistry, Genetics and Molecular Biology | 11 | 3% |
| Other | 55 | 17% |
| Unknown | 101 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2021.
All research outputs
#5,213,966
of 25,728,855 outputs
Outputs from Cochrane database of systematic reviews
#7,261
of 13,136 outputs
Outputs of similar age
#39,910
of 210,997 outputs
Outputs of similar age from Cochrane database of systematic reviews
#164
of 299 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,997 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 299 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.